Notably, aggregation and reduced PM association of dysferlin are observed in several muscular dystrophies including caveolinopathies and sarcoglycanopathies suggesting that dysferlin mis-targeting could also play a role in the pathogenesis of these diseases [21–24]. This evidence concerns the gene DYSF and muscular dystrophy.